Annual Meeting 2019 - Hepatocellular Carcinoma

ASCO Education Podcast

0:00
10:38
10
10

Annual Meeting 2019 - Hepatocellular Carcinoma

ASCO Education Podcast

Dr. James Harding (Memorial Sloan Kettering) is a board-certified medical oncologist specializes in caring for people with liver cancer, gallbladder cancer, and bile duct cancer, as well as other gastrointestinal cancers. In this week's episode, he discusses a new checkpoint inhibitor with monoclonal antibodies to programmed death receptor 1 (PD-1) for patients with Hepatocellular Carcinoma (HCC). He presents a clinical case and to highlight several aspects of immunotherapy for liver cancer.

Episodes
Date
Duration
Recommended episodes :

Cancer Topics – Medicinal Cannabis

ASCO Education Podcast

Oncology, Etc. - In Conversation with Dr. Quyen Chu

ASCO Education Podcast

Cancer Topics – Beyond Adjuvant Chemotherapy: Precision Oncology in Early-stage NSCLC

ASCO Education Podcast

The podcast ASCO Education Podcast has been added to your home screen.

Dr. James Harding (Memorial Sloan Kettering) is a board-certified medical oncologist specializes in caring for people with liver cancer, gallbladder cancer, and bile duct cancer, as well as other gastrointestinal cancers. In this week's episode, he discusses a new checkpoint inhibitor with monoclonal antibodies to programmed death receptor 1 (PD-1) for patients with Hepatocellular Carcinoma (HCC). He presents a clinical case and to highlight several aspects of immunotherapy for liver cancer.

Subscribe Install Share
ASCO Education Podcast

Thank you for your subscription

For a better experience, also consider installing the application.

Install